Medical Park Pharmacy Recalls Tadalafil 6 mg Capsules for Labeling Errors
MPRX, Inc. dba Medical Park Pharmacy is recalling Tadalafil 6 mg Capsules due to incorrect or missing lot and expiration dates and the use of expired components.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves labeling errors and the use of expired components, which aligns with the rubric for moderate severity involving minor labeling errors or low-risk contamination without reported serious injuries.
Plain-English summary
MPRX, Inc. dba Medical Park Pharmacy is recalling Tadalafil 6 mg Capsules. The recall involves 7 bottles of the product. The affected lots are 61229:26 and 61229:42, both with a use-by date of 03/25/2020.
The recall was initiated because of labeling errors, specifically incorrect or missing lot and/or expiration dates. Additionally, the products were compounded using expired components. The agency has classified this recall as Class II.
The affected products were distributed in Texas (TX). Consumers who have these specific lots of Tadalafil 6 mg Capsules should stop using them and contact the recalling firm or their healthcare provider for instructions on disposal or replacement.
The recalled product
- Product
- Tadalafil 6 mg Capsule
- Manufacturer
- MPRX, Inc. dba Medical Park Pharmacy
- Category
- Drug — Compounded Medication
- Affected units
- 7
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 61229:26 Use by: 03/25/2020
- 61229:42 Use by: 03/25/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 18 recalled by MPRX, Inc. dba Medical Park Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · MPRX, Inc. dba Medical Park Pharmacy
See all →- ModerateProgesterone 50 mg Capsules Recalled for Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Naltrexone Capsules Due to Labeling Errors
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Lidocaine/Prilocaine Cream Due to Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Finasteride/Biotin Due to Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Liothyronine Due to Expired Components
FDA (Drugs) · 2020-02-05
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateMasterPharm Recalls Tadalafil 7 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModeratePrescription Tadalafil tablets recalled for manufacturing process deviations
FDA (Drugs) · 2023-04-12
- ModerateMasterPharm Recalls Tadalafil 3 mg Capsules Due to Processing Control Issues
FDA (Drugs) · 2020-08-05
- HighTadalafil Tablets Recalled Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-05-03
- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Tadalafil 26 mg Capsules Due to Processing Controls
FDA (Drugs) · 2020-08-05